Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Clinical trial NCT06578247 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06578247
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-19
- Primary completion
- 2030-06-26
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.